CSL | Carlisle Companies Incorporated (NYSE:CSL) Receives Consensus Rating of “Buy” from Brokerages

Carlisle Companies Incorporated (NYSE:CSL) has earned an average rating of “Buy” from the nine research firms that are currently covering the stock, Marketbeat reports.One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company.The average 1-year price objective among analysts that have updated […]Daily Political

CSL | Comparing Vulcan International (OTCMKTS:VULC) & Carlisle Companies (OTCMKTS:CSL)

Vulcan International (OTCMKTS:VULC) and Carlisle Companies (NYSE:CSL) are both industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation.Profitability This table compares Vulcan International and Carlisle Companies’ net margins, return on equity and […]Daily […]

CSL | Australia signs two more COVID-19 vaccine deals

Australia signed two deals on Thursday to buy 40 million doses of COVID-19 vaccines from Novavax and 10 million from Pfizer and BioNTech as the country’s virus hot spot reported zero cases for the sixth straight day.Thursday’s agreements follow deals in September worth A$1.7 billion ($1.22 billion) with AstraZeneca and CSL Ltd for a total […]

CSL | Insights on the Anti-venom Global Market to 2025 – Featuring Pfizer, CSL Limited and Flynn Pharma Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anti-venom Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering.The anti-venom market is expected to register a CAGR of nearly 4.7% during the forecast period.Companies Mentioned Pfizer Inc.Laboratorios Silanes (Bioclon Institute) CSL Limited BTG PLC Merck & Co.Merck KGaA (Sigma Aldrich) Flynn Pharma (Micropharm) Boehringer Ingelheim […]

CSL | Equities Analysts Issue Forecasts for Carlisle Companies Incorporated’s Q4 2020 Earnings (NYSE:CSL)

Carlisle Companies Incorporated (NYSE:CSL) – Stock analysts at Jefferies Financial Group lowered their Q4 2020 earnings per share (EPS) estimates for Carlisle Companies in a research note issued to investors on Tuesday, October 20th.Jefferies Financial Group analyst S.Boroditsky now anticipates that the conglomerate will post earnings per share of $1.26 for the quarter, […]Zolmax News

CSL | FY2020 EPS Estimates for Carlisle Companies Incorporated Decreased by Oppenheimer (NYSE:CSL)

Carlisle Companies Incorporated (NYSE:CSL) – Oppenheimer lowered their FY2020 earnings per share (EPS) estimates for Carlisle Companies in a research report issued on Tuesday, October 20th.Oppenheimer analyst B.Blair now expects that the conglomerate will earn $5.95 per share for the year, down from their previous forecast of $6.05.Oppenheimer currently has a “Buy” […] Dakota Financial […]